FDA Panel Rejects Bid to Broaden Beta Blocker Indication - MedPage Today |
![]() |
MedPage TodayThe Cardiovascular and Renal Drugs Advisory Committee voted 8-0 against using nebivolol, made by Forest Laboratories, for "any heart failure population to ... read more |